株式会社極東書店トップ商品一覧Executive Functioning : A Comprehensive Guide for Clinical Practice.

商品詳細

Executive Functioning

Executive Functioning : A Comprehensive Guide for Clinical Practice. 実行機能

・ISBN 978-0-19-989032-3 paper US$ 88.00

¥20,618.- (税込) (※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。

お気に入り
著者・編者Suchy, Yana,
シリーズAACN Workshop Series
出版社(Oxford U. Pr., US)
出版年月2015
ページ数352 pp.
言語ENG
ニュース番号<628-2073>

解説

Executive Functioning: A Comprehensive Guide for Clinical Practice is the first book to offer an in-depth, comprehensive, and clinically applicable analysis of executive functioning (EF), as contrasted with "frontal-lobe functioning." Throughout the book, care is taken to stay true to the EF construct, and to use function, not structure, as the organising framework. The book is organised into four parts. The first part provides a brief overview of historical, theoretical, and clinical influences on how the construct has been conceptualized, studied, and ultimately defined. Part II describes five subdomains of EF, including Executive Cognitive Functions, Meta-tasking, Response Selection, Initiation/Maintenance, and Social Cognition. For each subdomain, the book reviews contributing elemental neurocognitive processes, neuroanatomic underpinnings, the utility of the subdomain in execution of daily tasks, as well as associated clinical syndromes. For each syndrome, cognitive and personality changes in daily life, as well as presentation during neuropsychological assessment, are described, and typical clinical populations characterized by each syndrome are briefly reviewed. Part III describes assessment methods, addressing both challenges and solutions in the neuropsychological evaluations of EF. An integration of information across record review, clinical interview, behavioural observation, and standardised assessment is advocated, as is consideration of assessment results within the contextual complexities of a given patient. Lastly, Part IV provides an overview of populations that are characterized by deficiencies in EF, with a chapter each devoted to neurodevelopmental, neurodegenerative, and neuropsychiatric disorders, as well as acquired brain insults and medical conditions.